Classification and epidemiology of hypersensitivity drug reactions

Immunology and Allergy Clinics of North America

Volumn 24, Issue 3, 2004, Pages 345-356

  Demoly, Pascal ^a   Hillaire Buys, Dominique ^b  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b LAPEYRONIE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; AMPICILLIN; ANESTHETIC AGENT; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; BETA LACTAM; CEFACLOR; CEPHALOSPORIN; CIPROFLOXACIN; CONTRAST MEDIUM; COTRIMOXAZOLE; DIHYDROERGOTAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROMYCIN; GENTAMICIN; GLAFENINE; INSULIN; ISONIAZID; LOCAL ANESTHETIC AGENT; MUSCLE RELAXANT AGENT; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PENICILLIN G; PROTAMINE; STREPTOGRAMIN; SULFONAMIDE; UNINDEXED DRUG; VANCOMYCIN;

ANAPHYLACTIC SHOCK; ANAPHYLAXIS; ATOPY; DRUG HYPERSENSITIVITY; EPIDEMIOLOGICAL DATA; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERVENTILATION SYNDROME; MAJOR HISTOCOMPATIBILITY COMPLEX; MENINGOCOCCOSIS; PAPULE; PRIORITY JOURNAL; RASH; RESPIRATORY TRACT INFECTION; REVIEW; RHEUMATIC FEVER; SOCIOECONOMICS; STEVENS JOHNSON SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TOXIC EPIDERMAL NECROLYSIS; VASCULITIS;

DRUG HYPERSENSITIVITY; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INCIDENCE; PREVALENCE; RISK FACTORS;

EID: 3042696954     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2004.03.010     Document Type: Review

References (55)

1. Johansson S., Hourihane J., Bousquet J., Bruijnzeel-Koomen C., Dreborg S., Haahtela T., et al. A revised nomenclature for allergy: an EAACI position statement from the EAACI nomenclature task force. Allergy. 56(9):2001;813-824
2. Preston S.L., Briceland L.L., Lesar T.S. Accuracy of penicillin allergy reporting. Am J Hosp Pharm. 51(1):1994;79-84
3. Demoly P., Bousquet J. Epidemiology of drug allergy. Curr Opin Allergy Clin Immunol. 1(4):2001;305-310
4. deShazo R., Kemp S. Allergic reactions to drugs and biological agents. JAMA. 278(22):1997;1895-1906
5. Vervloet D., Durham S. Adverse reactions to drugs. BMJ. 316(7143):1998;1511-1514
6. Adkinson N.F. Jr., Essayan D., Gruchalla R., Haggerty H., Kawabata T., Sandler J.D., et al. Task force report: future research needs for the prevention and management of immune-mediated drug hypersensitivity reactions. J Allergy Clin Immunol. 109(3):2002;S461-S478
7. Demoly P., Kropf R., Bircher A., Pichler W.J. Drug hypersensitivity questionnaire. Allergy. 54(9):1999;999-1003
8. Brockow K., Romano A., Blanca M., Ring J., Pichler W., Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy. 57(1):2002;45-51
9. Aberer W., Bircher A., Romano A., Blanca M., Campi P., Fernandez J., et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy. 58(9):2003;854-863
10. Torres M.J., Blanca M., Fernandez J., Romano A., de Weck A., Aberer W., et al. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy. 58(10):2003;961-972
11. Patterson R., DeSwarte R.D., Greenberger P.A., et al. Drug allergy and protocols for management of drug allergies. 2nd edition:1995;OceanSide Publications, Providence (RI)
12. Vervloet D., Arnaud A., Senft M., Dor P., Bongrand P., Charpin J., et al. Leukocyte histamine release to suxamethonium in patients with adverse reactions to muscle relaxants. J Allergy Clin Immunol. 75(3):1985;338-342
13. Brander C., Mauri-Hellweg D., Bettens F., Rolli H., Goldman M., Pichler W.J. Heterogeneous T cell responses to lactam-modified self-structures are observed in penicillin-allergic individuals. J Immunol. 155(5):1995;2670-2678
14. Gell P.G.H., Coombs R.R.A., Lachmann P.J. Clinical aspects of immunology. 3rd edition:1975;Blackwell, Oxford
15. Nyfeler B., Pichler W.J. The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy. 27(2):1996;175-181
16. Britschgi M., von Greyerz S., Burkhart C., Pichler W.J. Molecular aspects of drug recognition by specific T cells. Curr Drug Targets. 4(1):2003;1-11
17. Webster A.W., Thompson R.A. The ampicillin rash. Clin Exp Immunol. 18(4):1974;553-564
18. Battegay M., Opravil M., Wüttrich B., Lüthy R. Rash with amoxicillin-clavulanate therapy in HIV-infected patients. Lancet. 334(8671):1989;1100
19. Bates D.W., Cullen D.J., Laird N., Petersen L.A., Small S.D., Servi D., et al. Incidence of adverse drug events and potential adverse drug events. JAMA. 274(1):1995;29-34
20. Classen D.C., Pestotnik S.L., Evans R.S., Burke J.P. Computerized surveillance of adverse drug events in hospital patients. JAMA. 266(20):1991;2847-2851
21. Lazarou J., Pomeranz B.H., Corey P.N. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 279(15):1998;1200-1205
22. Pouyanne P., Haramburu F., Imbs J.L., Bégaud B. Admissions to hospital caused by adverse drug reactions: cross-sectional incidence study. BMJ. 320(7241):2000;1036
23. Smith C.C., Bennett P.M., Pearce H.M., Harrison P.I., Reynolds D.J., Aronson J.K., et al. Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines. Br J Clin Pharmacol. 42(4):1996;423-429
24. Hunziker T.H., Künzi U.-P., Braunschweig S., Zehnder D., Hoigne R. Comprehensive hospital drug monitoring (CHDM): adverse skin reactions, a 20-year survey. Allergy. 52(4):1997;388-393
25. Bigby M., Jick S., Jick H., Arndt K. Drug-induced cutaneous reactions: a report from the Boston Collaborative Drug Surveillance Program on 15, 438 consecutive inpatients, 1975 to 1982. JAMA. 256(24):1986;3358-3363
26. International Rheumatic Fever Study Group Allergic reactions to long-term benzathine penicillin prophylaxis for rheumatic fever. Lancet. 337(8753):1991;1308-1310
27. Mertes P.M., Laxenaire M.C., Alla F. Groupe d'Etudes des Reactions Anaphylactoides Peranesthesiques Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology. 99(3):2003;536-545
28. Ibia E.O., Schwartz R.H., Wiedermann B.L. Antibiotic rashes in children. Arch Dermatol. 136(7):2000;849-854
29. Burke P., Burne S.R. Allergy associated with ciprofloxacin. BMJ. 320(7236):2000;679
30. Katayama H., Yamaguchi K., Kozuka T., et al. Adverse reactions to ionic and nonionic contrast media: a report from the Japanese Committee on the Safety of Contrast Media. Radiology. 175(3):1990;621-628
31. Yocum M.W., Khan D.A. Assessment of patients who have experienced anaphylaxis: a 3-year survey. Mayo Clin Proc. 69(1):1994;16-23
32. van der Klauw M.M., Wilson J.H., Stricker B.H. Drug-associated anaphylaxis: 20 years of reporting in the Netherlands (1974-1994) and review of the literature. Clin Exp Allergy. 26(12):1996;1355-1363
33. Lenler-Petersen P., Hansen D., Andersen M., Sorensen H.T., Bille H. Drug-related fatal anaphylactic shock in Denmark 1968-1990: a study based on notifications to the Committee on Adverse Drug Reactions. J Clin Epidemiol. 48(9):1995;1185-1188
34. Sheikh A., Alves B. Hospital admissions for acute anaphylaxis: time trend study. BMJ. 320(7247):2000;1441
35. Pumphrey R.S. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy. 30(8):2000;1144-1150
36. Barranco P., Lopez-Serrano M.C. General and epidemiological aspects of allergic drug reactions. Clin Exp Allergy. 28(Suppl 4):1998;S61-S62
37. Haddi E., Charpin D., Tafforeau M., Kulling G., Lanteaume A., Kleisbauer J.P., et al. Atopy and systemic reactions to drugs. Allergy. 45(3):1990;236-239
38. Asero R. Detection of patients with multiple drug allergy syndrome by elective tolerance tests. Ann Allergy Asthma Immunol. 80(2):1998;185-188
39. Astarita C., Harris R.I., De Fusco R., Franzese A., Biscardi D., Mazzacca F.R., et al. An epidemiological study of atopy in children. Clin Allergy. 18(4):1988;341-350
40. Sanchez-Borges M., Capriles-Hulett A. Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity. Ann Allergy Asthma Immunol. 84(1):2000;101-106
41. Pastorello E.A., Zara C., Riario-Sforza G.G., Pravettoni V., Incorvaia C. Atopy and intolerance of antimicrobial drugs increase the risk of reactions to acetaminophen and nimesulide in patients allergic to nonsteroidal anti-inflammatory drugs. Allergy. 53(9):1998;880-884
42. Romano A., De Santis A., Romito A., Di Fonso M., Venuti A., Gasbarrini G.B., et al. Delayed hypersensitivity to aminopenicillins is related to major histocompatibility complex genes. Ann Allergy Asthma Immunol. 80(5):1998;433-437
43. Kowalski M.L., Woszczek G., Bienkiewicz B., Mis M. Association of pyrazolone drug hypersensitivity with HLA-DQ and DR antigens. Clin Exp Allergy. 28(9):1998;1353-1358
44. Mallal S., Nolan D., Witt C., Masel G., Martin A.M., Moore C., et al. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet. 359(9308):2002;727-732
45. Pirmohamed M., Lin K., Chadwick D., Park B.K. TNFalpha promoter region gene polymorphisms in carbamazepine-hypersensitive patients. Neurology. 56(7):2001;890-896
46. Vittorio C.C., Muglia J.J. Anticonvulsant hypersensitivity syndrome. Arch Intern Med. 155(21):1995;2285-2290
47. Petri M., Allbritton J. Antibiotic allergy in systemic lupus erythematosus: a case-control study. J Rheumatol. 19(2):1992;265-269
48. Smith J.W., Johnson J.E., Cluff L.E. Studies on the epidemiology of adverse drug reactions. II. An evaluation of penicillin allergy. N Engl J Med. 274(18):1966;998-1002
49. Khoury L., Warrington R. The multiple drug allergy syndrome: a matched-control retrospective study in patients allergic to penicillin. J Allergy Clin Immunol. 98(2):1996;462-464
50. Coopman S.A., Johnson R.A., Platt R., Stern R.S. Cutaneous disease and drug reactions in HIV infection. N Engl J Med. 328(23):1993;1670-1674
51. Buhl R., Jaffe H.A., Holroyd K.J., Wells F.B., Mastrangeli A., Saltini C., et al. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet. 334(8675):1989;1294-1298
52. Sanak M., Simon H.U., Szczeklik A. Leukotriene C4 synthase (LTC4s) promoter polymorphism and risk of aspirin-induced asthma. Lancet. 350(9091):1997;1599-1600
53. Lang D.M., Alpern M.B., Visintainer P.F., Smith S.T. Increased risk for anaphylactoid reaction from contrast media in patients on β-adrenergic blockers or with asthma. Ann Intern Med. 115(4):1991;270-276
54. Einarson T.R. Drug-related hospital admissions. Ann Pharmacother. 27(7-8):1993;832-840
55. Macy E. Elective penicillin skin testing and amoxicillin challenge: effect on outpatient antibiotic use, cost, and clinical outcomes. J Allergy Clin Immunol. 102(2):1998;281-285